CD36 antibody (FITC)
-
- Target See all CD36 Antibodies
- CD36
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This CD36 antibody is conjugated to FITC
-
Application
- Flow Cytometry (FACS), Immunoprecipitation (IP)
- Specificity
- CD36 Molecule of 88 kd. Its epitope has been mapped to amino acids 155-183.
- Purification
- Gel filtration
- Immunogen
- Human tonsil cells /PBM.
- Clone
- SMO-SM0
- Isotype
- IgM
- Top Product
- Discover our top product CD36 Primary Antibody
-
-
- Application Notes
-
Approved: Flo, IP
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- 50 mM sodium phosphate, pH 7.5, 500 mM potassium chloride, 150 mM sodium chloride, 5 % Glycerol, 0.2 % BSA, 0.04 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Do not freeze. Product is photosensitive and should be protected from light.
- Storage
- 4 °C
- Storage Comment
- Store at 4°C. Do not freeze. Protect from light.
-
-
PC12 cells have caveolae that contain TrkA. Caveolae-disrupting drugs inhibit nerve growth factor-induced, but not epidermal growth factor-induced, MAPK phosphorylation." in: The Journal of biological chemistry, Vol. 275, Issue 48, pp. 37846-52, (2000) (PubMed).
: "Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells." in: The Journal of biological chemistry, Vol. 272, Issue 28, pp. 17858-66, (1997) (PubMed).
: "Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps." in: The Journal of cell biology, Vol. 131, Issue 6 Pt 1, pp. 1421-33, (1996) (PubMed).
: "
-
PC12 cells have caveolae that contain TrkA. Caveolae-disrupting drugs inhibit nerve growth factor-induced, but not epidermal growth factor-induced, MAPK phosphorylation." in: The Journal of biological chemistry, Vol. 275, Issue 48, pp. 37846-52, (2000) (PubMed).
-
- Target
- CD36
- Alternative Name
- CD36 (CD36 Products)
- Background
-
Name/Gene ID: CD36
Synonyms: CD36, Cluster determinant 36, FAT, Fatty acid translocase, Glycoprotein IIIb, gp4, GPIIIB, GPIV, PAS-4 protein, PAS IV, PASIV, Platelet collagen receptor, Platelet glycoprotein IV, SCARB3, Thrombospondin receptor, BDPLT10, CD36 antigen, CHDS7, gp3B, PAS-4, Platelet glycoprotein 4 - Gene ID
- 948
- UniProt
- P16671
- Pathways
- TLR Signaling, Peptide Hormone Metabolism, Response to Growth Hormone Stimulus, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Hepatitis C, Toll-Like Receptors Cascades, Lipid Metabolism, S100 Proteins
-